๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Israel
Clinical trial register · Israel

Studies with an Israeli investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2428 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:47 UTC
2428
Studies in scope
all four open statuses
1246
Recruiting now
open to new participants
455
Lead sponsors
across recruiting studies
Top sites
Jerusalem 843 Haifa 736 Tel Aviv 685 Ramat Gan 651 Petah Tikva 612
Narrow the register
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC112 Beth Israel Deaconess Medical Center88 National Cancer Institute (NCI)88 AbbVie86 Janssen Research & Development, LLC68
Site location
Jerusalem843 Haifa736 Tel Aviv685 Ramat Gan651 Petah Tikva612
All 102 locations
Target enrolment
to

Trials in this register

2428 of 2428 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Active, closed
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer
DrugsTarlatamab·Durvalumab
Amgen
Phase 3
563
Haifa, Jerusalem, Kfar Saba, Petah Tikva
2024-06-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801Crohn's Disease
DrugTulisokibart
Merck Sharp & Dohme LLC
Phase 3
1,200
Afula, Ashkelon, Haifa, Holon, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2024-06-05
Recruiting
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
NCT06583876Functional Mitral Regurgitation
Bio Refine Ltd.
Not applicable
15
Petah Tikva
2024-06-03
Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
NCT06439277Obesity, Weight Gain
DrugTirzepatide
Eli Lilly and Company
Phase 3
300
Afula, Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2024-06-03
Active, closed
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
NCT05975021Cardiogenic Shock
Windtree Therapeutics
Phase 1/2
20
Rehovot
2024-06-01
Recruiting
Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit
NCT06154382Thyroid; Functional Disturbance
Meir Medical Center
Observational
350
Kfar Saba
2024-06-01
Recruiting
Doppler Flow in Tubal Ectopic Pregnancy in Diagnosis as a Predictor of Treatment Success - Conservative and MTX Treatment
NCT07541937Ectopic Pregnancy
Meir Medical Center
Observational
60
Kfar Saba
2024-06-01
Not yet open
CVA in Patients Suffering From Decreased Consciousness, Confusion or Headaches to an Emergency Room
NCT03377062CVA
Rambam Health Care Campus
Observational
120
Haifa
2024-06-01
Recruiting
Video Game Play to Alleviate Adolescent Anxiety
NCT05923944Anxiety, Anxiety Disorders and Symptoms
School of Health Sciences Geneva
Not applicable
150
Haifa
2024-06-01
Recruiting
Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia
NCT06946940Fibromyalgia
DrugCannabis oil
Rambam Health Care Campus
Phase 2
150
Haifa
2024-05-30
Recruiting
Impella RP Flex with Smart Assist
NCT06637644Right Ventricular (RV) Dysfunction
Abiomed Inc.
Observational
200
2024-05-29
Active, closed
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
NCT06360354Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
DrugsAnvumetostat·Modified FOLFIRINOX·RMC-6236·Nab-paclitaxel
Amgen
Phase 1
120
2024-05-29
Recruiting
Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
NCT06355154Diabetes in Pregnancy
Hadassah Medical Organization
Not applicable
120
Jerusalem
2024-05-28
Recruiting
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
NCT06465160Myelodysplastic Syndromes
Minovia Therapeutics Ltd.
Phase 1
15
Jerusalem
2024-05-27
Active, closed
Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
NCT06422936Basal Cell Carcinoma
Highlight Therapeutics
Phase 2
50
Beersheba, Haifa, Jerusalem, Rehovot
2024-05-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Afula, Beersheba, Haifa, Jerusalem, Nahariya, Petah Tikva, Tel Aviv, Tel Litwinsky
2024-05-24
Recruiting
Multi-Center Clean Air Randomized Controlled Trial in COPD
NCT06376994Chronic Obstructive Pulmonary Disease (COPD)
JHSPH Center for Clinical Trials
Phase 3
770
2024-05-24
Active, closed
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
NCT06303713Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
DrugsPluvicto·Carboplatin
Dana-Farber Cancer Institute
Phase 1
37
2024-05-22
Active, closed
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
NCT06336291Glioblastoma
DrugsOnfekafusp alfa·Lomustine
Philogen S.p.A.
Phase 2
90
2024-05-22
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
DrugIanalumab
Novartis Pharmaceuticals
Phase 3
550
Haifa, Ramat Gan
2024-05-21
Active, closed
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
NCT06226571Acute Myeloid Leukemias
DrugRevumenib
Syndax Pharmaceuticals
Phase 1
96
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Petah Tikva, Tel Aviv, แบ”erifin, Haifa, Hadera, Jerusalem, Ashkelon, Tel Litwinsky
2024-05-20
Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
NCT06353386Prostatic Neoplasms, Castration-Resistant
DrugsFludrocortisone acetate·Opevesostat·Cabazitaxel·Olaparib
Merck Sharp & Dohme LLC
Phase 1/2
220
Haifa, Petah Tikva, Ramat Gan
2024-05-20
Active, closed
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06158841Multiple Myeloma
DrugsElotuzumab·Etentamig·Carfilzomib·Selinexor
AbbVie
Phase 3
421
Petah Tikva, Jerusalem, Ramat Gan, Tel Aviv
2024-05-19
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Ramat Gan
2024-05-15
Active, closed
Phase 3 Study of ALXN1850 in Treatment-Naรฏve Pediatric Participants With HPP
NCT06079359Hypophosphatasia
DrugALXN1850
Alexion Pharmaceuticals, Inc.
Phase 3
30
Ashkelon
2024-05-14
Recruiting
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
NCT06821919Diabetes Mellitus, Kidney Disease
Western Galilee Hospital-Nahariya
Observational
70
Nahariya
2024-05-13
Recruiting
Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers
NCT06474104Primary Mitochondrial Diseases
Minovia Therapeutics Ltd.
Observational
100
Ramat Gan
2024-05-12
Active, closed
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934Dermatitis Atopic
DrugAmlitelimab
Sanofi
Phase 3
1,541
Afula, Beersheba, Haifa, Jerusalem, Petah Tikva
2024-05-08
Recruiting
Endovascular AAA Intervention Using the GOREยฎ EXCLUDERยฎ Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
NCT06218875AAA - Abdominal Aortic Aneurysm
W.L.Gore & Associates
Observational
2,000
Tel Aviv
2024-05-07
Recruiting
Stepped-Care for Suicidal Youth and Children
NCT07321171Suicidal Ideation and Behavior
Shira Barzilay
Not applicable
350
Petah Tikva
2024-05-07
Active, closed
The DreamChanger Intervention in Combination With Imagery Rehearsal Therapy for Children's Nightmares
NCT06410118Nightmare
Tel Aviv University
Not applicable
120
Tel Aviv
2024-05-07
Active, closed
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
DrugNerandomilast
Boehringer Ingelheim
Phase 3
1,666
Beer Yaakov, Haifa, Jerusalem, Tel Aviv
2024-05-06
Recruiting
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
NCT06297993PSC
PSC Partners Seeking a Cure
Observational
2,000
2024-05-06
Active, closed
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311Gastroesophageal Cancer
DrugsTrifluridine/Tipiracil·Sacituzumab tirumotecan·Irinotecan·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
450
Hadera, Haifa, Jerusalem, Petah Tikva, Tel Aviv
2024-05-03
Active, closed
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
NCT06945627Severe Mental Illness, Inflammation, Viral Infections, Mood Disorders
Sara Poletti
Observational
408,551
Haifa
2024-05-02
Active, closed
The Effect of Asthma Flare-up Clinic After Exacerbation
NCT06201728Asthma, Asthma Attack
Tel-Aviv Sourasky Medical Center
Not applicable
230
Tel Aviv
2024-05-01
Recruiting
Speculum Insertion During Embryo Transfer
NCT06210451IVF
Wolfson Medical Center
Not applicable
416
Tel Aviv
2024-05-01
Recruiting
Vitamin C Administration and Triglycerides Level in Critical Care Patients
NCT06206759Hypertriglyceridemia
Meir Medical Center
Observational
2,000
Kfar Saba
2024-05-01
Recruiting
Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease
NCT06494826Crohn Disease
Weizmann Institute of Science
Observational
40
Afula
2024-05-01
Recruiting
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
NCT06164730Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease
DrugVERVE-102
Verve Therapeutics, Inc.
Phase 1
85
Rehovot
2024-04-30
Active, closed
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
DrugRetatrutide
Eli Lilly and Company
Phase 3
10,000
Ashkelon, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan, Rehovot
2024-04-30
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961End Stage Kidney Disease
DrugCSL300
CSL Behring
Phase 2/3
3,110
Afula, Ashkelon, Haifa, Holon, Nahariya, Petah Tikva, Ramat Gan, Rehovot
2024-04-27
Recruiting
A Platform Trial for Gram Negative Bloodstream Infections
NCT06537609Gram-negative Bacteremia
Sunnybrook Health Sciences Centre
Not applicable
2,500
Ramat Gan
2024-04-24
Recruiting
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naรฏve Myelofibrosis and Moderate Thrombocytopenia
NCT05980806Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia
DrugsMomelotinib·Pacritinib·Selinexor·Ruxolitinib
Karyopharm Therapeutics Inc
Phase 2
58
Tel Aviv, Haifa
2024-04-22
Recruiting
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
NCT06333262Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Obinutuzumab
Inhye Ahn
Phase 2
60
2024-04-22
Active, closed
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
NCT06194448Lung Cancer
DrugsOsimertinib·Pemetrexed·Paclitaxel·Cisplatin
AstraZeneca
Phase 2
76
Haifa, Jerusalem, Tel Aviv
2024-04-21
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NCT06172296Ganglioneuroblastoma, Nodular, Neuroblastoma
DrugsDinutuximab·Isotretinoin·CDDP·Doxorubicin
National Cancer Institute (NCI)
Phase 3
478
2024-04-19
Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
NCT06319820Non-Muscle Invasive Bladder Neoplasms
DrugGemcitabine
Janssen Research & Development, LLC
Phase 3
641
Haifa, Jerusalem, Ramat Gan, Safed, Tel Aviv
2024-04-18
Active, closed
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
NCT06408935Crohn's Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
120
Haifa, Holon, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2024-04-17
Recruiting
CEReBral AutorEgulation in Non-cardiac SuRgery and Relationship to Postoperative DeliriUm State
NCT06133842Perioperative/Postoperative Complications, Postoperative Cognitive Dysfunction, Postoperative Delirium, EEG With Periodic Abnormalities
Beth Israel Deaconess Medical Center
Observational
100
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Haifa, Rehovot, Safed, Tel Litwinsky
2024-04-16
Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
NCT05908331In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
Concept Medical Inc.
Not applicable
492
2024-04-16
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176Breast Neoplasms
DrugsLiposomal doxorubicin·Sacituzumab tirumotecan·Nab-paclitaxel·Capecitabine
Merck Sharp & Dohme LLC
Phase 3
1,200
Haifa, Jerusalem, Petah Tikva, Ramat Gan
2024-04-14
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652Heart Failure and Impaired Kidney Function
AstraZeneca
Phase 3
3,850
Afula, Ashkelon, Beersheba, Beโ€™er Yaโ€˜aqov, Haifa, Holon, Jerusalem, Kfar Saba
2024-04-12
Recruiting
Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous
NCT06325007Induction of Labor Affected Fetus / Newborn
Holy Family Hospital, Nazareth, Israel
Not applicable
142
Nazareth
2024-04-11
Active, closed
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
NCT06307431Renal Cell Carcinoma
DrugsIntismeran autogene·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2
272
2024-04-10
Recruiting
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT06236438Non-Small Cell Lung Cancer
DrugsLivmoniplimab·Budigalimab·Pemetrexed·Cisplatin
AbbVie
Phase 2/3
840
Jerusalem, Haifa
2024-04-10
Recruiting
Castor Oil Ingestion and Balloon Catheter for Labor Induction in Multiparous
NCT06335017Induction of Labor
Holy Family Hospital, Nazareth, Israel
Not applicable
216
Nazareth
2024-04-10
Active, closed
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
NCT06029660Aortic Aneurysm, Abdominal
Shape Memory Medical, Inc.
Not applicable
180
2024-04-05
Active, closed
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
NCT06073132Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc.
Phase 2/3
80
Tel Aviv
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
Avalyn Pharma Inc.
Phase 2
375
2024-04-03
Recruiting
Safety and Feasibility Evaluation of ALVIV Laser Based Treatment for Fecal Incontinence
NCT07436676Fecal Incontinence (FI)
Alviv Ltd.
Not applicable
12
Kfar Saba
2024-04-03
Recruiting
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
NCT05915377Delirium, Delirium in Old Age, Delirium With Dementia, Delirium Superimposed on Dementia
Penn State University
Not applicable
1,050
2024-04-03
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Non Small Cell Lung Cancer
DrugsSacituzumab tirumotecan·Pemetrexed·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
780
Haifa, Jerusalem, Petah Tikva, Ramat Gan
2024-04-03
Recruiting
Cross Modal Correlation of EEG and MRI Functional Connectivity: An Investigative Study
NCT07539506MRI, Functional MRI
Assaf-Harofeh Medical Center
Not applicable
1,500
Zrifin
2024-04-02
Active, closed
Operative Hysteroscopy Versus Suction Curettage for Surgical Termination of Early Pregnancy Loss (Miscarriage)
NCT06309927Early Pregnancy Loss, Intrauterine Adhesion
Assaf-Harofeh Medical Center
Not applicable
100
Beโ€™er Yaโ€˜aqov
2024-04-01
Active, closed
Clemastine Treatment in Individuals With Williams Syndrome
NCT06087757Williams Syndrome
Sheba Medical Center
Phase 2
30
Ramat Gan, Tel Aviv
2024-04-01
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
579
Haifa, Jerusalem, Nazareth, Petah Tikva, Tel Aviv
2024-03-29
Active, closed
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
NCT06254950Ulcerative Colitis
DrugZasocitinib
Takeda
Phase 2
213
Ashdod, Beersheba, Jerusalem, Ramat Gan
2024-03-29
Active, closed
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
NCT06268873Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
2,554
Ashkelon, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv
2024-03-29
Recruiting
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
NCT06093672Polycythemia Vera
DrugsGivinostat·Hydroxyurea
Italfarmaco
Phase 3
220
Jerusalem, Tel Aviv, Haifa
2024-03-26
Active, closed
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
NCT06257875Ulcerative Colitis
DrugsLutikizumab·Humira·Adalimumab
AbbVie
Phase 2
156
แบ”erifin, Jerusalem, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2024-03-23
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588Neoplasms, Head and Neck
DrugDostarlimab
GlaxoSmithKline
Phase 3
864
Ashdod, Haifa, Jerusalem, Tel Aviv
2024-03-21
Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
NCT06150664Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma, Head and Neck Squamous Cell Carcinoma
Compass Therapeutics
Phase 1
85
2024-03-19
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Jerusalem, Petah Tikva
2024-03-15
Active, closed
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
NCT06297603Type 2 Diabetes
DrugRetatrutide
Eli Lilly and Company
Phase 3
320
Atlit, Beersheba, Herzliya, Holon, Jerusalem, Ramat Gan, Sakhnin
2024-03-15
Recruiting
The Predictive Role of Immune-inflammatory Biomarkers and Their Interaction With the Oxytocin System in Trauma-related Psychotherapy Responsiveness
NCT06348472Posttraumatic Stress Disorder
Shalvata Mental Health Center
Observational
100
Hod HaSharon
2024-03-14
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Afula, Beersheba, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2024-03-13
Recruiting
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05923073Crohn's Disease
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
120
Beersheba, Beโ€™er Yaโ€˜aqov, Jerusalem, Petah Tikva, Rehovot
2024-03-13
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
NCT05509777Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
90
Beersheba, Israel, Jerusalem, Petah Tikva, Rehovot
2024-03-13
Recruiting
Pain Selective Anesthesia for Labor Mobility (PSALM Study): a Randomized Controlled Trial of Combined Lidocaine - Chlorprocaine for Labor Epidural Analgesia
NCT06302257Labor Pain
DrugLidocaine
Hadassah Medical Organization
Phase 4
303
Jerusalem, Rehovot
2024-03-12
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT05939414Oligometastatic Prostate Cancer (OMPC)
DrugsPiflufolastat·Pluvicto
Novartis Pharmaceuticals
Phase 3
450
Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv
2024-03-12
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
NCT06202248Non-metastatic Prostate Cancer, Locally Recurrent Prostate Cancer
Alpha Tau Medical LTD.
Not applicable
10
Haifa
2024-03-12
Active, closed
Dostarlimab and Cobolimab in Advanced Cervical Cancer
NCT06238635Cervical Cancer, Advanced Cervical Carcinoma, Metastatic Cervical Cancer, Metastatic Cervical Carcinoma
DrugsCobolimab·Dostarlimab
Meghan Shea
Phase 2
66
2024-03-11
By invitation
Fecal Microbiome Transplantation From Healthy Donors to Individuals With Fibromyalgia
NCT06424041Fibromyalgia
Rambam Health Care Campus
Phase 2
100
Haifa
2024-03-11
Active, closed
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
NCT06257264Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer
DrugsBGB-43395·Fulvestrant
BeiGene
Phase 1
103
Haifa, Jerusalem
2024-03-11
Active, closed
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
NCT06318273Metastatic Castration-Resistant Prostate Cancer
AbbVie
Phase 1
152
Ramat Gan, Haifa, Jerusalem
2024-03-08
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma
DrugElranatamab
Massachusetts General Hospital
Phase 2
32
2024-03-08
Recruiting
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
NCT05646381Aortic Stenosis
Novartis Pharmaceuticals
Phase 2
502
Beersheba, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2024-03-07
Recruiting
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461Crohn's Disease
DrugZasocitinib
Takeda
Phase 2
268
Ashdod, Beersheba, Jerusalem, Kfar Saba, Ramat Gan
2024-03-05
Active, closed
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
DrugLepodisiran
Eli Lilly and Company
Phase 3
17,300
Afula, Beersheba, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2024-03-05
Recruiting
Sheba Healthspan Research Population (SHARP) Trial - Sheba Longevity Center Diagnostic and Intervention Protocol to Lower Biological Age in Older Adults
NCT07596576Healthy Aging, Healthspan, Biological Age, Intrinsic Capacity
Sheba Medical Center
Not applicable
1,500
Ramat Gan
2024-03-01
Recruiting
Southeastern Europe Microcirculation Registry
NCT06393478Angina, Microvascular, Coronary Microvascular Dysfunction, Coronary Artery Disease
Institute for Cardiovascular Diseases Dedinje
Observational
900
Tel Aviv
2024-03-01
Active, closed
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
NCT06241118Dermatitis Atopic
DrugsPimecrolimus·Amlitelimab·Tacrolimus
Sanofi
Phase 3
464
Beersheba, Ramat Gan, Tel Aviv
2024-02-29
Active, closed
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
NCT05896189Breast Cancer, Cognitive Impairments
NRG Oncology
Not applicable
386
2024-02-29
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
NCT05827081Early Breast Cancer
DrugsLeuprolide·Goserelin·Exemestane·Ribociclib
Novartis Pharmaceuticals
Phase 3
1,400
Beersheba, Petah Tikva, Ramat Gan, Tel Aviv
2024-02-28
Active, closed
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
NCT06282159Myasthenia Gravis, Generalized
DrugClaseprubart
Dianthus Therapeutics
Phase 2
65
Haifa, Ramat Gan, Safed
2024-02-23
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
NCT06030063Cesarean Delivery, General Anesthesia
Yale University
Observational
5,000
2024-02-22
Recruiting
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT06121843Multiple Myeloma
DrugsBMS-986393·Mezigdomide·Iberdomide·Elranatamab
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
187
2024-02-22
Rows per page Showing 901–1000 of 2428
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-israel?page=10

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,428 studies in total at the last sync on 26 Sep 2026, 19:47 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Israel?

1,246 of the 2,428 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:47 UTC sync. A further 108 have not yet opened recruitment, 1,015 are active but closed to new participants, and 59 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Multiple Myeloma (57) Breast Cancer (52) Chronic Lymphocytic Leukemia (24) Carcinoma, Non-Small-Cell Lung (23) Prostate Cancer (21) Heart Failure (21) Crohn's Disease (21) Ovarian Cancer (21) Non-Small Cell Lung Cancer (20) Obesity (18) Acute Myeloid Leukemia (18) Crohn Disease (16) Ulcerative Colitis (16) Stroke (15) Non-small Cell Lung Cancer (15)
→

Browse trials by site location

Jerusalem (843) Haifa (736) Tel Aviv (685) Ramat Gan (651) Petah Tikva (612) Kfar Saba (252) Beersheba (251) Afula (127) Rehovot (117) Nahariya (106) Ashkelon (98) Holon (93) Tel Litwinsky (82) แบ”erifin (75) Ashdod (72)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.